Syncom Formulations (India) Ltd.
 
Bse Code: 524470 | NSE CODE: N.A. | Sector: Pharmaceuticals & Drugs
Prev Close
Open
MarketCap(` in Cr.)
Volume (No. of shares)
52 W LOW
52 W HIGH
LOW
HIGH

price chart

News

No News found.

financial summary

` in Cr.MAR 2011MAR 2010yoy(%)
Net Sales76.3285.41-10.63
Total Expenditure73.3776.19-3.70
Operating Profit3.319.56-65.34
Interest0.500.55-8.30
PBDT2.819.01-68.80
Depreciation2.362.178.75
PAT0.204.41-95.37

Research

No Research found.

Ratios

Earnings Per Share (Rs)0.09
Book NAV by Share(Rs)36.49
EBIT Margin(%)1.24
PAT Margin (%)0.27
ROCE(%)1.24
Price by Book(x)0.84
Yield(%)1.63
PAT Growth(%)-95.37
Total Debt by Equity(x)0.12

More About this company on NDTV Profit

No Interviews/Opinions found.

announcement / Events


Dateannouncement / events
May 19, 2012
01:14 PM
Financial Results for March 31, 2012

shareholding pattern

DescriptionPercent of Share(%)
Total Promoter62.88
Govt0.00
FII0.00
Institutions0.00

Profit Board

No Post available.!

Mutual fund holding

No Data found

Corporate Information

Kedarmal Bankda
Chairman
Vijay Bankda
Managing Director
Vinod Kabra
Director
 
Registered Office:
7
Niraj Industrial Estate,
Mumbai,Maharashtra.
Tel : +91-022- 30887744
Fax : +91-022- 30887755
 
Registrars Details:
Ankit Consultancy Pvt Ltd
2nd Floor, Alankar Point , 4-A Rajgarh Kothi,
Geeta Bhawan Chouraha,
A B Road,
Indore

peer companies

CompanyPRICE (`) 
Solvay Pharma India Ltd.
2,141.55
Zandu Realty Ltd
1,308.650.28
Wyeth Ltd.
857.000.52
Amrutanjan Health Care Ltd.
748.100.80
Novartis India Ltd.
718.001.03

MARKETS

TOP VIDEO

46:26